Serum associated leucocyte locomotion inhibition and leucocyte motility in malignant melanoma: effect of BCG treatment.
D001500:BCG Vaccine / Q000627:therapeutic use*; D002465:Cell Movement; D002634:Chemotaxis, Leukocyte; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000276:immunology*; D008263:Macrophage Migration-Inhibitory Factors / Q000097:blood*; D008297:Male; D008545:Melanoma / Q000276:immunology* / Q000628:therapy; D009367:Neoplasm Staging; D011379:Prognosis
D001500:BCG Vaccine; D008263:Macrophage Migration-Inhibitory Factors